How Much Evidence Do We Have on the Central Effects of Botulinum Toxin in Spasticity and Dystonia?

doi 10.5772/64763
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Dystonia, Spasticity and Botulinum Toxin Therapy: Rationale, Evidences and Clinical Context

2012English

Deleterious Systemic Effects of OSA: How Much Evidence Do We Need?

Thorax
PulmonaryRespiratory Medicine
2015English

Botulinum Toxin Type a Versus Botulinum Toxin Type B for Cervical Dystonia

2003English

Stroke Thrombolysis in England, Wales and Northern Ireland: How Much Do We Do and How Much Do We Need?

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2010English

Botulinum Toxin Type a and Electrical Stimulation in the Treatment of Spasticity

The Japanese Journal of Rehabilitation Medicine
2017English

Standardisation of Synovial Tissue Infiltrate Analysis: How Far Have We Come? How Much Further Do We Need to Go?

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2006English

The Evaluation of Botulinum Toxin Injection Effect for Poststroke Spasticity Treatment

Turk Noroloji Dergisi
Neurology
2017English

A Beautician’s Dystonia: Long-Lasting Effect of Botulinum Toxin

Case Reports in Neurological Medicine
2014English

Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache: Table.

Neurology: Clinical Practice
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy